Latest Updates

Organised for the first time in India, the event witnessed and welcomed regulatory bodies, international organisations and more…

The company had posted net profit of Rs 288.45 crore in July-September period of 2018-19

This gives time to the maker of OxyContin time to try to reach legal settlement the company says is worth $10 billion

The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold…

Dr Ge Li wins ‘CEO of the year’ and John Chiminski a ‘lifetime achievement award’, with 11 further outstanding winners unveiled

Income from operations rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period

The new facility that will be established in Dehradun, Uttarakhand, in northern India, is expected to be fully operational by 2022…

The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…

Novartis's biosimilar, called Ziextenzo, is aimed at helping cancer patients boost infection-fighting white blood cells during…

Specially formulated analgesic is designed to give extra strength for tough headache